Lodestar Investment Counsel’s Novartis NVS Stock Holding History

Lodestar Investment Counsel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-102,364	Closed	-$6.64M	–	157
2016 Q1	$6.64M	Sell	102,364 -160	-0.2%	-$10.9K	0.95%	44
2015 Q4	$7.9M	Buy	102,524 +676	+0.7%	+$53.7K	1.25%	31
2015 Q3	$8.39M	Sell	101,848 -590	-0.6%	-$52.5K	1.41%	28
2015 Q2	$9.03M	Sell	102,438 -1,996	-2%	-$183K	1.42%	28
2015 Q1	$9.23M	Buy	+104,434	New	+$9.26M	1.43%	28

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Lodestar Investment Counsel's NVS Position: Q2 2016 in Review

Lodestar Investment Counsel sold out of Novartis (NVS) in Q2 2016, closing a stake of 102,364 shares — an estimated $6.64M sold.

Lodestar Investment Counsel first reported a position in NVS in Q1 2015 and held it in 5 quarters. The position peaked at $9.23M in Q1 2015. 879 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

Lodestar Investment Counsel reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
Lodestar Investment Counsel sold 102,364 Novartis shares in Q2 2016, an estimated $6.64M.
Lodestar Investment Counsel first reported a position in Novartis in Q1 2015 and held it in 5 quarters.
Lodestar Investment Counsel's Novartis position peaked at $9.23M in Q1 2015.
879 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Lodestar Investment Counsel's 13F filing for Q2 2016, filed 14 Jul 2016.